Showing results (1061-1070 of 1,182) with videos related to

Sort By:
Pageof 119
Diabetes, Obesity & Metabolism|February 2, 2021
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trialAhmad Haidar, Jean-Francois Yale, Leif Erik Lovblom, et al.
Diabetes Care|August 24, 2023
Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 DiabetesCimon Song, Sharon Dhaliwal, Priya Bapat, et al.
Cancer Biology & Therapy|September 6, 2018
Enhancing the efficacy of glycolytic blockade in cancer cells <i>via</i> RAD51 inhibitionJohn J Wilson, Kin-Hoe Chow, Nathan J Labrie, et al.
Plos One|March 23, 2013
Genetic determinants of phosphate response in DrosophilaClemens Bergwitz, Mark J Wee, Sumi Sinha, et al.
BMC Neuroscience|November 22, 2001
PKA, PKC, and AKAP localization in and around the neuromuscular junctionG A Perkins, L Wang, L J Huang, et al.
Journal of Clinical Microbiology|January 4, 2001
Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup CT Popovic, S Schmink, N A Rosenstein, et al.
Plos One|May 1, 2018
Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 DiabetesDaniel Scarr, Leif E Lovblom, Nancy Cardinez, et al.
International Journal of Pediatric Otorhinolaryngology|September 19, 2021
Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformationsJuliana Bonilla-Velez, Kathryn B Whitlock, Sheila Ganti, et al.
Diabetes Care|February 1, 2024
Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 DiabetesBarbara H Braffett, Laure El Ghormli, James W Albers, et al.
Diabetes, Obesity & Metabolism|December 21, 2019
Low-dose empagliflozin as adjunct-to-insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacyBruce A Perkins, Nima Soleymanlou, Julio Rosenstock, et al.
Pageof 119